Hormone Refractory Breast Cancer Market: Is Estimated to Experience a Notable Rise in the Span of Coming Years

According to AMR’s prediction, Hormone refractory breast cancer, also known as hormone-resistant breast cancer or hormone-independent breast cancer, is a type of breast cancer that no longer responds to hormonal therapy. Hormone therapy is a common treatment for breast cancer that targets the hormones estrogen and progesterone, which promote the growth of certain types of breast …